Medically reviewed by Matthew Wosnitzer, MD Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer ...

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Experts developed consensus recommendations through the modified Delphi process for metastatic prostate cancer management ...

Discover comprehensive insights into approved therapeutics and research developments targeting Prostate-Specific Membrane Antigen (PSMA). This product provides detailed competitor analysis, R&D stages ...

The first patient in a phase 2 clinical trial evaluating 67Cu-SAR-bisPSMA for patients with metastatic castration-resistant ...

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

Nubeqa plus hormone therapy improved outcomes in metastatic prostate cancer, reducing disease progression and showing a ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves a combination of therapies, including ...